Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis
The epidermal growth factor receptor (EGFR) is an essential driver of oncogenic signalling, and EGFR inhibitors are some of the earliest examples of successful targeted therapies in multiple types of cancer. The tractability of EGFR as a therapeutic target is overshadowed by the inevitable drug resi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2021-10-01
|
Series: | Open Biology |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/10.1098/rsob.210033 |